APA (7th ed.) Citation

Mancini, L., Casagranda, S., Gautier, G., Peter, P., Lopez, B., Thorne, L., . . . Bisdas, S. (2022). CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing. European Journal of Nuclear Medicine & Molecular Imaging, 49(7), 2377. https://doi.org/10.1007/s00259-022-05676-1

Chicago Style (17th ed.) Citation

Mancini, Laura, et al. "CEST MRI Provides Amide/amine Surrogate Biomarkers for Treatment-naïve Glioma Sub-typing." European Journal of Nuclear Medicine & Molecular Imaging 49, no. 7 (2022): 2377. https://doi.org/10.1007/s00259-022-05676-1.

MLA (9th ed.) Citation

Mancini, Laura, et al. "CEST MRI Provides Amide/amine Surrogate Biomarkers for Treatment-naïve Glioma Sub-typing." European Journal of Nuclear Medicine & Molecular Imaging, vol. 49, no. 7, 2022, p. 2377, https://doi.org/10.1007/s00259-022-05676-1.